» Articles » PMID: 39338507

Sulfate-Reducing Bacteria Induce Pro-Inflammatory TNF-α and INOS Via PI3K/Akt Pathway in a TLR 2-Dependent Manner

Overview
Journal Microorganisms
Specialty Microbiology
Date 2024 Sep 28
PMID 39338507
Authors
Affiliations
Soon will be listed here.
Abstract

, resident gut sulfate-reducing bacteria (SRB), are found to overgrow in diseases such as inflammatory bowel disease and Parkinson's disease. They activate a pro-inflammatory response, suggesting that may play a causal role in inflammation. Class I phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway regulates key events in the inflammatory response to infection. Dysfunctional PI3K/Akt signaling is linked to numerous diseases. Bacterial-induced PI3K/Akt pathway may be activated downstream of toll-like receptor (TLR) signaling. Here, we tested the hypothesis that (DSV) may induce tumor necrosis factor alpha (TNF-α) and inducible nitric oxide synthase (iNOS) expression via PI3K/Akt in a TLR 2-dependent manner. RAW 264.7 macrophages were infected with DSV, and protein expression of p-Akt, p-p70S6K, p-NF-κB, p-IkB, TNF-α, and iNOS was measured. We found that DSV induced these proteins in a time-dependent manner. Heat-killed and live DSV, but not bacterial culture supernatant or a probiotic , significantly caused PI3K/AKT/TNF/iNOS activation. LY294002, a PI3K/Akt signaling inhibitor, and TL2-C29, a TLR 2 antagonist, inhibited DSV-induced PI3K/AKT pathway. Thus, DSV induces pro-inflammatory TNF-α and iNOS via PI3K/Akt pathway in a TLR 2-dependent manner. Taken together, our study identifies a novel mechanism by which SRB such as may trigger inflammation in diseases associated with SRB overgrowth.

Citing Articles

Activation of NR2A-Wnt-TLR2 Signaling Axis in Satellite Glial Cells of the Dorsal Root Ganglion Contributes to Neuropathic Pain Induced by Nerve Injury in Diabetic Mice.

Zhang Y, Zhu D, Wang M, Yi Y, Feng Y, Zhou C Mol Neurobiol. 2025; .

PMID: 39964585 DOI: 10.1007/s12035-025-04754-3.

References
1.
Akira S, Takeda K, Kaisho T . Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001; 2(8):675-80. DOI: 10.1038/90609. View

2.
Camacho-Soto A, Gross A, Searles Nielsen S, Dey N, Racette B . Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries. Parkinsonism Relat Disord. 2018; 50:23-28. PMC: 5943158. DOI: 10.1016/j.parkreldis.2018.02.008. View

3.
Carloni S, Rescigno M . The gut-brain vascular axis in neuroinflammation. Semin Immunol. 2023; 69:101802. DOI: 10.1016/j.smim.2023.101802. View

4.
Hayashi F, Smith K, Ozinsky A, Hawn T, Yi E, Goodlett D . The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001; 410(6832):1099-103. DOI: 10.1038/35074106. View

5.
Guo M, Wang X . Pathological mechanism and targeted drugs of ulcerative colitis: A review. Medicine (Baltimore). 2023; 102(37):e35020. PMC: 10508406. DOI: 10.1097/MD.0000000000035020. View